497 related articles for article (PubMed ID: 8318817)
41. The success of locoregional, low-dose recombinant interleukin-2 therapy in tumor-bearing mice is dependent on the time of rIL-2 administration.
Everse LA; Bernsen MR; Dullens HF; Den Otter W
J Exp Ther Oncol; 1996 Jul; 1(4):231-6. PubMed ID: 9414409
[TBL] [Abstract][Full Text] [Related]
42. Indomethacin inhibits kidney metastasis in bomirski melanoma-bearing hamsters, and modulates natural killer cytotoxic activity of tumor hosts in vivo and in vitro.
Bigda J; Mysliwski A
Anticancer Res; 1998; 18(5A):3549-54. PubMed ID: 9858938
[TBL] [Abstract][Full Text] [Related]
43. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
44. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
Koo GC; Dumont FJ; Tutt M; Hackett J; Kumar V
J Immunol; 1986 Dec; 137(12):3742-7. PubMed ID: 3782794
[TBL] [Abstract][Full Text] [Related]
45. Soluble glucan and lymphokine-activated killer (LAK) cells in the therapy of experimental hepatic metastases.
Sherwood ER; Williams DL; McNamee RB; Jones EL; Browder IW; Di Luzio NR
J Biol Response Mod; 1988 Apr; 7(2):185-98. PubMed ID: 3283299
[TBL] [Abstract][Full Text] [Related]
46. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
Yamauchi A; Bloom ET
J Immunol; 1993 Nov; 151(10):5535-44. PubMed ID: 8228244
[TBL] [Abstract][Full Text] [Related]
47. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
Nagler A; Lanier LL; Phillips JH
J Immunol; 1988 Oct; 141(7):2349-51. PubMed ID: 3262658
[TBL] [Abstract][Full Text] [Related]
48. Modulation of murine natural killer cells by a granulocytosis-inducing tumor.
Pollack SB; Lee MY; Cohen E; Lottsfeldt JL; Rosse C
Cancer Res; 1989 Jan; 49(1):174-8. PubMed ID: 2908844
[TBL] [Abstract][Full Text] [Related]
49. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
Melamed R; Rosenne E; Shakhar K; Schwartz Y; Abudarham N; Ben-Eliyahu S
Brain Behav Immun; 2005 Mar; 19(2):114-26. PubMed ID: 15664784
[TBL] [Abstract][Full Text] [Related]
50. Hypothalamic control of the generation of mature natural killer lymphocytes in bone marrow and spleen of the mouse.
Belluardo N; Mudó G; Cardile V; Migliorati G; Riccardi C; Cella S; Bindoni M
Nat Immun Cell Growth Regul; 1990; 9(1):26-35. PubMed ID: 2184351
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of natural killer cell activity in MoLV leukemogenesis: evidence for tumor-cell-mediated suppression.
Ofir R; Weinstein Y; Rager-Zisman B
Nat Immun Cell Growth Regul; 1988; 7(2):77-86. PubMed ID: 2842667
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of loss of natural killer activity in P815 ascites tumor bearing DBA/2 mice.
Saxena RK; Saxena QB; Adler WH
Nat Immun Cell Growth Regul; 1983-1984; 3(1):34-42. PubMed ID: 6235448
[TBL] [Abstract][Full Text] [Related]
53. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex.
Lu L; Shen RN; Zhou SZ; Srivastava C; Harrington M; Miyazawa K; Wu B; Lin ZH; Ruscetti S; Broxmeyer HE
Int J Hematol; 1991 Apr; 54(2):117-24. PubMed ID: 1660735
[TBL] [Abstract][Full Text] [Related]
54. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
55. NK activity in carrageenan-treated mice.
Quan PC; Kolb JP; Lespinats G
Immunology; 1980 Aug; 40(4):495-503. PubMed ID: 6159311
[TBL] [Abstract][Full Text] [Related]
56. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
Lotzová E; Savary CA; Herberman RB
J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
[TBL] [Abstract][Full Text] [Related]
57. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
Hsu KH; Friedman H
J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
[TBL] [Abstract][Full Text] [Related]
58. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
[TBL] [Abstract][Full Text] [Related]
59. Analysis of low natural killer cell activity in 89Sr-treated mice.
Mellen PF; Lust JA; Bennett M; Kumar V
Eur J Immunol; 1982 May; 12(5):442-5. PubMed ID: 6212259
[TBL] [Abstract][Full Text] [Related]
60. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
